Ann: Fluence Q2 2022 Update Presentation, page-9

Hi Dungiven.

These are the kind of announcements that make me optimistic about China.

They are up-selling from packaged Aspiral plants to retrofit SUBRE and now to O&M SUBRE. Tells me that MABR is validated, and China wants to adopt more MABR in the future.

Most importantly, as more plants sold, and data is being generated and analyzed, more applied research can be done to come up with combination of MABR plus other technologies to make MABR even more compelling with better effluent and lower OPEX. And the more applied research is being done out of China, it is shared with other FLC sales centres in Africa, Asia, et al. That was how I understood Cambodia was able to come aboard the MABR bandwagon so quickly, using what was learnt in China.